AGM
GOSS icon

Alpine Global Management’s Gossamer Bio GOSS Stock Holding History

Alpine Global Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,200
Closed -$657K – 310
2025
Q4 		$657K Buy
13,200
+6,200
+89% +$17.7K 0.14% 87
2025
Q3 		$7K Buy
+7,000
New +$15.4K ﹤0.01% 200

Other funds holding GOSS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Alpine Global Management's GOSS Position: Q1 2026 in Review

Alpine Global Management opened a new position in Gossamer Bio (GOSS) in Q1 2026: 32,827 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #218 among its holdings. This is a return to the name: Alpine Global Management previously reported a position in GOSS as recently as Q4 2019.

Alpine Global Management first reported a position in GOSS in Q4 2019 and has held it in 2 quarters since. The position peaked at $261K in Q4 2019. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Alpine Global Management held 32,827 shares of Gossamer Bio worth $10.8K as of Q1 2026.
  • Gossamer Bio was a new Alpine Global Management position in Q1 2026.
  • Gossamer Bio made up ﹤0.01% of Alpine Global Management's portfolio in Q1 2026, its #218 holding.
  • Alpine Global Management first reported a position in Gossamer Bio in Q4 2019 and has held it in 2 quarters since.
  • Alpine Global Management's Gossamer Bio position peaked at $261K in Q4 2019.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Alpine Global Management's 13F filing for Q1 2026, filed 15 May 2026.